Abcellera Biologics Inc (ABCL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ABCL | AZN | AMGN | GILD | VRTX |
| Company | Abcellera Biologics Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 3.80 | 84.55 | 316.08 | 123.89 | 415.61 |
| High | 4.01 | 85.15 | 321.42 | 124.00 | 416.27 |
| Low | 3.42 | 84.22 | 314.00 | 117.54 | 406.67 |
| Last | 3.91 | 84.58 | 320.20 | 118.84 | 409.47 |
| Change | -0.62 | +0.81 | +4.61 | -4.56 | -6.78 |
| % Change | -13.69% | +0.97% | +1.46% | -3.70% | -1.63% |
| Volume | 13,529,800 | 4,106,100 | 2,665,300 | 9,065,900 | 1,357,900 |
| 20-Day Average Volume | 4,880,385 | 4,359,765 | 2,346,990 | 7,000,785 | 1,357,435 |
| Previous Close | 4.53 | 83.77 | 315.59 | 123.40 | 416.25 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 5.42 | 83.35 | 298.87 | 120.55 | 418.22 |
| 20-Day Raw Stochastic | 17.45% | 87.23% | 92.05% | 45.51% | 22.83% |
| 20-Day Relative Strength | 34.95 | 58.66 | 66.82 | 51.07 | 47.94 |
| Weighted Alpha | +43.03 | +32.40 | +6.33 | +23.69 | -18.14 |
| Today's Opinion | 40% Buy | 100% Buy | 56% Buy | 88% Buy | 56% Sell |
| Previous Opinion | 40% Buy | 100% Buy | 56% Buy | 100% Buy | 56% Sell |
| Last Month's Opinion | 100% Buy | 100% Buy | 8% Sell | 88% Buy | 56% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -29.55% since 10/31/25 | +2.65% since 10/31/25 | +7.29% since 10/31/25 | -0.79% since 10/31/25 | -3.78% since 10/31/25 |
| Low | 3.42 on 11/07/25 | 80.48 on 11/04/25 | 292.12 on 11/03/25 | 117.54 on 11/07/25 | 403.16 on 11/04/25 |
| High | 5.60 on 11/03/25 | 85.15 on 11/07/25 | 322.98 on 11/05/25 | 124.10 on 11/06/25 | 430.71 on 11/04/25 |
| 1-Month | |||||
| %Chg | -32.24% since 10/07/25 | -1.50% since 10/07/25 | +8.34% since 10/07/25 | +1.76% since 10/07/25 | -0.20% since 10/07/25 |
| Low | 3.42 on 11/07/25 | 80.48 on 11/04/25 | 288.00 on 10/31/25 | 114.02 on 10/31/25 | 402.58 on 10/13/25 |
| High | 6.51 on 10/08/25 | 86.48 on 10/08/25 | 322.98 on 11/05/25 | 124.61 on 10/21/25 | 432.76 on 10/23/25 |
| 3-Month | |||||
| %Chg | -7.78% since 08/07/25 | +13.42% since 08/07/25 | +12.47% since 08/07/25 | +7.76% since 08/07/25 | +9.01% since 08/07/25 |
| Low | 3.42 on 11/07/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 362.50 on 08/11/25 |
| High | 6.51 on 10/08/25 | 86.57 on 10/06/25 | 322.98 on 11/05/25 | 124.61 on 10/21/25 | 432.76 on 10/23/25 |
| 6-Month | |||||
| %Chg | +94.53% since 05/07/25 | +20.71% since 05/07/25 | +16.08% since 05/07/25 | +20.16% since 05/07/25 | -5.83% since 05/07/25 |
| Low | 1.94 on 05/23/25 | 66.16 on 05/14/25 | 261.43 on 05/14/25 | 95.29 on 05/08/25 | 362.50 on 08/11/25 |
| High | 6.51 on 10/08/25 | 86.57 on 10/06/25 | 322.98 on 11/05/25 | 124.61 on 10/21/25 | 484.56 on 07/10/25 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,168,437 | 262,316,768 | 172,421,616 | 147,457,504 | 103,890,320 |
| Shares Outstanding, K | 298,833 | 3,101,404 | 538,481 | 1,240,807 | 253,719 |
| Annual Sales | 28,830,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -162,860,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 17,080,000 | 14,457,000,000 | 9,179,000,000 | 7,769,000,000 | 2,964,700,000 |
| Last Quarter Net Income | -34,730,000 | 2,450,000,000 | 1,432,000,000 | 3,052,000,000 | 1,032,900,000 |
| 60-Month Beta | 0.70 | 0.34 | 0.45 | 0.32 | 0.36 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.12 on 08/07/25 | 2.38 on 11/06/25 | 5.64 on 11/04/25 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 11/06/25 | 11/06/25 | 11/04/25 | 10/30/25 | 11/03/25 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 08/22/25 | 0.790 on 09/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 11/21/25 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 18.33 | 14.43 | 15.07 | 27.19 |